1. Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma
   Ravi Salgia, 2016, Expert Review of Molecular Diagnostics CrossRef
2. Best practices for the extraction of genomic DNA from formalin‐fixed paraffin‐embedded tumor tissue for cancer genomic profiling tests
   Hirofumi Inoue et al, 2021, Pathology International CrossRef
3. EGFR Testing in Advanced Non–Small-Cell Lung Cancer, A Mini-Review
   Yuri Sheikine et al, 2016, Clinical Lung Cancer CrossRef
4. Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non–Small-cell Lung Cancer
   Edward Kim et al, 2018, Clinical Lung Cancer CrossRef
5. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations
   Suja Pillai et al, 2017, Experimental and Molecular Pathology CrossRef
6. Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei
   Lilli Saarinen et al, 2017, PLOS ONE CrossRef
7. Implementation of next generation sequencing in clinical molecular diagnostic laboratories: advantages, challenges and potential
   Rajesh R. Singh et al, 2016, Expert Review of Precision Medicine and Drug Development CrossRef
8. ALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncology
   C. Heydt et al, 2016, Annals of Oncology CrossRef
9. Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers
   Suet-Feung Chin et al, 2018, Experimental and Molecular Pathology CrossRef
10. An optimizedBRCA1/2next-generation sequencing for different clinical sample types
    Yoonjung Kim et al, 2020, Journal of Gynecologic Oncology CrossRef